| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19.0B | $18.4B | $17.3B | $15.6B | $13.3B | $12.0B | $12.2B | $11.9B |
| Cost of Revenue | $9.6B | $9.3B | $8.9B | $8.2B | $6.7B | $6.1B | $6.3B | $6.2B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.7B | $1.7B | $1.6B | $1.5B | $1.2B | $1.1B | $1.1B | $1.1B |
| Operating Income | $3.3B | $3.2B | $2.8B | $2.4B | $2.1B | $0.4B | $0.5B | $0.5B |
| Net Income | $2.1B | $2.0B | $1.7B | $1.5B | $1.3B | $0.2B | $0.3B | $0.3B |
| EPS (Basic) | $6.86 | $6.50 | $5.47 | $4.70 | $4.05 | $3.03 | $3.34 | $3.17 |
| EPS (Diluted) | $6.85 | $6.49 | $5.47 | $4.69 | $4.04 | $0.74 | $0.90 | $0.92 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $34.4B | $32.4B | $31.4B | $29.1B | $25.0B | $23.4B | $22.7B | $21.6B |
| Current Assets | $2.5B | $2.4B | $2.4B | $2.4B | $1.7B | $1.5B | $1.6B | $1.6B |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $3.9B | $4.1B | $4.2B | $3.4B | $2.4B | $2.3B | $3.1B | $2.7B |
| Stockholders' Equity | $12.0B | $11.4B | $10.5B | $9.7B | $9.0B | $8.5B | $8.1B | $7.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.3B | $3.9B | $3.6B | $3.2B | $2.8B | $2.5B | $2.4B | $2.2B |
| Investing Cash Flow | $-3.3B | $-2.6B | $-3.7B | $-4.4B | $-2.5B | $-1.9B | $-1.7B | $-1.2B |
| Capital Expenditures | $1.9B | $1.9B | $1.6B | $1.5B | $1.3B | $1.2B | $1.2B | $1.1B |
| Financing Cash Flow | $-0.9B | $-1.4B | $0.1B | $1.3B | $-0.3B | $-0.6B | $-0.6B | $-1.1B |